- Facultat de Medicina
Centre
![Foto de - Facultat de Medicina](/img/noimage.png)
![Foto de AstraZeneca (United Kingdom)](/img/noimage_org.png)
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von AstraZeneca (United Kingdom) (8)
2023
-
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells
Science advances, Vol. 9, Núm. 42, pp. eadi0244
2022
-
Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy
Diabetes Therapy, Vol. 13, Núm. 7, pp. 1281-1298
-
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Diabetes Therapy, Vol. 13, Núm. 5, pp. 873-888
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes
Circulation, Vol. 141, Núm. 17, pp. 1360-1370
2019
-
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
Database, Vol. 2019, pp. 1-67
2017
-
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
New England Journal of Medicine, Vol. 377, Núm. 13, pp. 1228-1239
2006
-
Neurohormonal blockade in patients with heart failure at discharge from hospital
Anales de Medicina Interna, Vol. 23, Núm. 10